HearingAssist Control vs Otofonix Groove

The HearingAssist Control is a mid-priced OTC behind-the-ear hearing aid available at $549. In our lab testing, it earned a B grade with a SoundScore of 3.3/5, placing it in the top 77% of OTC hearing aids tested. This device demonstrates solid speech performance, scoring above the category average in both quiet and noisy environments. Speech in quiet earned a solid 3.4/5, while speech in noise scored 2.0/5—above average for the category but only mixed in absolute terms. Feedback handling is excellent at 5.0/5, meaning wearers should experience minimal whistling during normal use. The HearingAssist Control has notable limitations. Music streaming scored 0.0/5, indicating this device does not support audio streaming functionality—a significant gap compared to many competitors in this price range. Own-voice comfort scored 2.1/5, which is below the category average and may result in a hollow or boomy perception of your own voice. For shoppers considering this price tier, alternatives like the Yeasound RIC800 (4.73/5) and Sony CRE-E10 (4.66/5) offer substantially higher overall sound performance. The HearingAssist Control may suit buyers prioritizing speech clarity and feedback stability who don't need streaming capabilities, but most users would benefit from exploring higher-scoring options at similar price points.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE ranks #38 of 39 devices in the prescription hearing aid category, placing it in the bottom 5% of its class. In our testing, the Groove demonstrated excellent feedback handling at 5.0/5, scoring 0.28 points above the category average. This represents a genuine strength, with the device maintaining stability during our standardized challenge motions. However, speech performance was significantly limited, with speech in quiet scoring 1.0/5 (2.40 points below the category average of 3.40) and speech in noise also at 1.0/5 (1.11 points below average). Music streaming was not functional in our tests, scoring 0.0/5 against a category average of 2.76. Own-voice comfort also fell well below typical prescription hearing aid performance at 0.4/5, which is 2.30 points below the category average. At this price point, several lower-cost alternatives delivered stronger overall performance in our testing. Consumers seeking value in the prescription category may want to explore other options, though those requiring robust feedback control in a rechargeable BTE format may find the Groove's stability noteworthy despite its other limitations.